Related Experiment Video
Updated: Aug 7, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Lung mass caused by Phoma exigua
Evangelos Balis1, Aristea Velegraki, Archodula Fragou
1Third Department of Internal Medicine, Medical School, University of Athens, Sotiria General and Chest Hospital, Athens, Greece. evanbalis@yahoo.co.uk
Abstract:
We describe a well documented case of a fatal Phoma exigua lung infection in a patient with acute myeloid leukaemia and diabetes. The infection was histology and culture proven and a PCR assay was developed for detecting P. exigua DNA in deparaffinized lung-biopsy material. Confirmation of rare fungal pathogen infections requires a multidisciplinary approach involving clinical observations, mycology, histopathology and radiology.
Insights
A fatal Phoma exigua lung infection occurred in an acute myeloid leukemia patient with diabetes. Diagnosis required a multidisciplinary approach, including a new PCR assay for rare fungal pathogen detection.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Hematology
Background:
- Rare fungal infections pose diagnostic challenges, particularly in immunocompromised patients.
- Phoma exigua is an uncommon fungal pathogen, rarely implicated in human disease.
- Acute myeloid leukemia (AML) and diabetes mellitus are significant risk factors for opportunistic infections.
Observation:
- A documented case of fatal Phoma exigua lung infection is presented.
- The patient had a history of acute myeloid leukemia and diabetes mellitus.
- Clinical, histological, and microbiological data were meticulously collected.
Findings:
- The Phoma exigua infection was confirmed through histology and fungal culture.
- A novel Polymerase Chain Reaction (PCR) assay was developed to detect P. exigua DNA in lung biopsy samples.
- The PCR assay demonstrated utility in identifying the rare fungal pathogen.
Implications:
- This case highlights the importance of considering rare fungal pathogens in immunocompromised individuals.
- The developed PCR assay offers a potential tool for rapid and accurate diagnosis of P. exigua infections.
- A multidisciplinary diagnostic approach, integrating clinical, mycological, histopathological, and radiological findings, is crucial for confirming rare fungal infections.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Atypical Pneumonia
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Cryptococcal Meningitis
Leishmaniasis
